Watton Corey Michael
SEC Form 4 insider trading activity
Watton Corey Michael has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, Watton Corey Michael is listed as Director at ZEVRA THERAPEUTICS, INC. Inside the rolling window, Watton Corey Michael reported no open-market purchases and 1 open-market sale totaling $138K in ZVRA.
Companies traded
Other insiders at ZVRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$138K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Watton Corey Michael made?
Watton Corey Michael has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Watton Corey Michael trade?
Watton Corey Michael has filed SEC Form 4 disclosures for 1 company, including ZVRA.
When was Watton Corey Michael's most recent SEC Form 4 filing?
Watton Corey Michael's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is Watton Corey Michael's total buy and sell value in the current window?
Inside the rolling retention window, Watton Corey Michael bought $0 and sold $138K based on SEC Form 4 filings.
What was Watton Corey Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,300 ZVRA shares on 2026-08-10, worth $138K, per SEC Form 4 filings.